Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

2.

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.

Mariappan P, Ballantyne Z, N'Dow JM, Alhasso AA.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004742. Review.

PMID:
16034945
3.

Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.

Jost W, Marsalek P.

Clin Auton Res. 2004 Aug;14(4):220-7. Review.

PMID:
15316838
4.

Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.

Kitta T, Miyazato M, Chancellor MB, de Groat WC, Nonomura K, Yoshimura N.

J Urol. 2010 Aug;184(2):762-8. doi: 10.1016/j.juro.2010.03.106. Epub 2010 Jun 19.

5.

Duloxetine: a new approach for treating stress urinary incontinence.

Moore K.

Int J Gynaecol Obstet. 2004 Jul;86 Suppl 1:S53-62. Review.

PMID:
15302567
6.

Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J.

Eur Urol. 2007 Jan;51(1):67-74. Epub 2006 Sep 15. Review.

PMID:
17014950
7.

Targeting serotonin and norepinephrine receptors in stress urinary incontinence.

Thor KB.

Int J Gynaecol Obstet. 2004 Jul;86 Suppl 1:S38-52. Review.

PMID:
15302566
8.

The use of Duloxetine in the treatment of male stress urinary incontinence.

Fink KG, Huber J, W├╝rnschimmel E, Schmeller NT.

Wien Med Wochenschr. 2008;158(3-4):116-8. doi: 10.1007/s10354-007-0494-7.

PMID:
18330528
9.

Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.

Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC; Duloxetine Urinary Incontinence Study Group.

J Urol. 2003 Oct;170(4 Pt 1):1259-63. Erratum in: J Urol. 2004 Jan;171(1):360.

PMID:
14501737
10.

Safety and tolerability of duloxetine in women with stress urinary incontinence.

Oelke M, Roovers JP, Michel MC.

BJOG. 2006 May;113 Suppl 1:22-6. Review.

12.

Update on duloxetine for the management of stress urinary incontinence.

Basu M, Duckett JR.

Clin Interv Aging. 2009;4:25-30. Epub 2009 May 14. Review.

13.
14.

Pharmacotherapy for stress urinary incontinence : present and future options.

Zinner NR, Koke SC, Viktrup L.

Drugs. 2004;64(14):1503-16. Review.

PMID:
15233589
15.

Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence.

Tsakiris P, de la Rosette JJ, Michel MC, Oelke M.

Eur Urol. 2008 Jan;53(1):53-9. Epub 2007 Oct 1. Review.

PMID:
17920183
16.

Pharmacotherapy for stress urinary incontinence.

Castro-Diaz D, Amoros MA.

Curr Opin Urol. 2005 Jul;15(4):227-30. Review.

PMID:
15928510
17.

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.

Zinner NR.

Expert Opin Investig Drugs. 2003 Sep;12(9):1559-66. Review.

PMID:
12943499
18.

[Pharmacotherapy of stress incontinence].

Jost WH, Marsalek P, Michel MC.

Dtsch Med Wochenschr. 2005 Oct 14;130(41):2337-42. Review. German.

PMID:
16231235
19.

Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.

Miyazato M, Kaiho Y, Kamo I, Chancellor MB, Sugaya K, de Groat WC, Yoshimura N.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F264-71. doi: 10.1152/ajprenal.90241.2008. Epub 2008 May 14.

20.

Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.

Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG.

Eur Urol. 2006 Jun;49(6):1075-8. Epub 2006 Feb 6.

PMID:
16481094
Items per page

Supplemental Content

Write to the Help Desk